Galacto-oligosaccharides Market Size Worth $1,739.89 Million By 2030 | CAGR: 9.7%

The global galacto-oligosaccharides market size is expected to reach USD 1,739.89 Million by 2030, according to a new study by Polaris Market Research. The report “Galacto-oligosaccharides Market Share, Size, Trends, Industry Analysis Report, By Source (Plants, Animals, Microorganisms); By Application; By Product; By Function Type; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The industry is expanding as a result of both the increased prevalence of chronic diseases and the rising demand for confectionery goods. GOS is being used more frequently as a low-calorie sweetener in bread, drinks, milk products, and confectionery goods. The usage of galactooligosaccharides has increased significantly as a result of the aging population, which is also supplemented by gastrointestinal issues and anxiety concerns.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/global-galacto-oligosaccharides-market/request-for-sample

Furthermore, the rising geriatric population, along with the rising anxiety disease and gastrointestinal issues, is boosting the demand for the product. For instance, as per the World Health Organization (WHO), One in six people on the globe will be 60 or older by 2030. By this point, there will be 1.4 billion people over the age of 60, up from 1 billion in 2020. The number of persons in the globe who are 60 years old or older will have to double by 2050 (2.1 billion). Between 2020 and 2050, the population of individuals 80 or older is projected to treble, reaching 426 million.

Moreover, World Economic Forum data reports that anxiety problems affect 275 million people worldwide. With a range of 2.5% to 6.5% of people in each country, that represents about 4% of the world's population. There are 170 million female patients with anxiety, 62 percent more than the 105 million male patients.

Also, as per the Centers for Disease Control and Prevention (CDC), 14.8 million adults have been diagnosed with ulcers. 7.9 million emergency hospital visits were made with gastrointestinal illnesses as the major indication. Galacto-oligosaccharide has many positive effects on dietary items, including improved bowel habits, decreased IBD inflammation, and improved blood lipid and cholesterol levels.

Galacto-oligosaccharides Market Report Highlights

• Food and Beverages segment growing with a lucrative CAGR over the forecast period. They are extensively utilized in the making of numerous foods, including bread, pastries, butter, cheese, curd, yogurt, and many others, due to their relative consistency and low-calorie sweetness.
• The liquid segment accounted for a significant revenue share. Compared to powder form galacto-oligosaccharide, liquid galacto-oligosaccharide is more in demand. These are used for the efficient operation of the human body, and customers' increased health awareness and knowledge of this fact are driving up industry demand.
• Asia-Pacific growing with the fastest CAGR over the forecast period. The region is growing because prebiotics is becoming more popular among consumers, and because plant-based GOS variations are being developed.
• The global market players are Biological Co., Ltd., Baolingbao Biology Company, Nissin Sugar Inc., Royal Friesland Campina N.V, Saputo Dairy UK, and Yakult Pharmaceuticals Company Limited.

Polaris Market Research has segmented the galacto-oligosaccharides market report based on source, product, application, function type, and region:

Galacto-oligosaccharides, Source Outlook (Revenue - USD Million, 2018 - 2030)

• Plants
• Animals
• Microorganisms

Galacto-oligosaccharides, Product Outlook (Revenue - USD Million, 2018 - 2030)

• Syrup
• Powder

Galacto-oligosaccharides, Function Type Outlook (Revenue - USD Million, 2018 - 2030)

• Prebiotic
• Sweetener

Galacto-oligosaccharides, Application Outlook (Revenue - USD Million, 2018 - 2030)

• Food and Beverage
• Pharmaceuticals,
• Personal Care
• Animal Feed
• Others

Galacto-oligosaccharides, Regional Outlook (Revenue - USD Million, 2018 - 2030)

• North America
  • U.S
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa